ipharmaservicesAug 14NICE Recommends Vertex's £1.6 Million One-Time Gene Therapy Casgevy for Beta-Thalassaemia | iPharmaCenter
ipharmaservicesJul 20NICE Endorses Almirall's Ebglyss for Treating Moderate to Severe Atopic Dermatitis | iPharmaCenter
ipharmaservicesJul 14Hemgenix Receives Managed Access Recommendation for Treating Severe Haemophilia B in Adults | iPharmaCenter
ipharmaservicesJun 13NICE said NO to Keytruda plus trastuzumab for HER2-positive gastric cancer | 2024 | iPharmaCenter
ipharmaservicesJun 7Servier Laboratories' Tibsovo Combined with Azacitidine Recommended by NICE for Adult Patients with Newly Diagnosed AML with IDH1 Mutation | iPharmaCenter
ipharmaservicesMay 15NICE recommended AbbVie's Aquipta for migraine | United Kingdom |Healthcare News | iPharmaCenter
ipharmaservicesMay 3NICE recommended the use of AI-derived solutions to detect stroke | iPharmaCenter
ipharmaservicesMay 1NICE Assessment Outcomes | Untied Kingdom | Drug News | Updates | 2024 | iPharmaCenter
ipharmaservicesSep 8, 2023NICE ASSESSMENT OUTCOMES | 2023 | (2/N) | UK HEALTHCARE NEWS | IPHARMACENTER
ipharmaservicesApr 6, 2023NICE ASSESSMENT OUTCOMES | 2023 (1/N) United Kingdom | Healthcare | Pharma | News | iPharmaCenter
ipharmaservicesMar 8, 2023NICE ASSESSMENT OUTCOMES | 2022 United Kingdom | Healthcare | Pharma | News | Blogs | iPharm
